These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 21719143)

  • 1. Signet ring cell adenocarcinoma of the lung with an EML4-ALK fusion gene mimicking mucinous (colloid) adenocarcinoma: a case report.
    Ohba T; Sugio K; Kometani T; Yamaguchi M; Hamatake M; Nosaki K; Takeoka H; Kitajima H; Hirai F; Seto T; Taguchi K; Nishiyama K; Shida Y; Ichinose Y
    Lung Cancer; 2011 Sep; 73(3):375-8. PubMed ID: 21719143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eml4-alk-positive lung adenocarcinoma with signet-ring cells.
    Kawahara A; Akiba J; Abe H; Yamaguchi T; Taira T; Azuma K; Kage M
    Diagn Cytopathol; 2014 May; 42(5):460-3. PubMed ID: 23166115
    [No Abstract]   [Full Text] [Related]  

  • 3. Cytomorphological features of ALK-positive lung adenocarcinomas: psammoma bodies and signet ring cells.
    Pareja F; Crapanzano JP; Mansukhani MM; Bulman WA; Saqi A
    Cancer Cytopathol; 2015 Mar; 123(3):162-70. PubMed ID: 25557162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequent ALK rearrangement and TTF-1/p63 co-expression in lung adenocarcinoma with signet-ring cell component.
    Yoshida A; Tsuta K; Watanabe S; Sekine I; Fukayama M; Tsuda H; Furuta K; Shibata T
    Lung Cancer; 2011 Jun; 72(3):309-15. PubMed ID: 21036415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A case of mucinous cystic adenocarcinoma of the lung with signet-ring cells].
    Nakamura H; Tanaka Y; Hori H; Ishiguro S; Hara H; Mori T
    Kyobu Geka; 1993 Oct; 46(11):990-3. PubMed ID: 8230921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary signet-ring carcinoma (SRC) of the lung: a population-based epidemiologic study of 262 cases with comparison to adenocarcinoma of the lung.
    Ou SH; Ziogas A; Zell JA
    J Thorac Oncol; 2010 Apr; 5(4):420-7. PubMed ID: 20130484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recurrence of lung adenocarcinoma after an interval of 15 years revealed by demonstration of the same type of EML4-ALK fusion gene.
    Tsukamoto Y; Kanamori K; Watanabe T; Mikami K; Ieki R; Nakano T; Kajimoto K; Hirota S
    Pathol Res Pract; 2014 Dec; 210(12):1112-6. PubMed ID: 25238939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recurrent EML4-ALK-associated lung adenocarcinoma with a slow clinical course.
    Murakami S; Yokose T; Saito H; Sakuma Y; Matsukuma S; Hasegawa C; Kondo T; Oshita F; Ito H; Tsuboi M; Nakayama H; Kameda Y; Noda K; Yamada K
    Lung Cancer; 2010 Sep; 69(3):361-4. PubMed ID: 20659620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EML4-ALK fusion transcripts, but no NPM-, TPM3-, CLTC-, ATIC-, or TFG-ALK fusion transcripts, in non-small cell lung carcinomas.
    Shinmura K; Kageyama S; Tao H; Bunai T; Suzuki M; Kamo T; Takamochi K; Suzuki K; Tanahashi M; Niwa H; Ogawa H; Sugimura H
    Lung Cancer; 2008 Aug; 61(2):163-9. PubMed ID: 18242762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of EML4-ALK fusion genes in non-small cell lung cancer patients with clinical features associated with EGFR mutations.
    Shaozhang Z; Xiaomei L; Aiping Z; Jianbo H; Xiangqun S; Qitao Y
    Genes Chromosomes Cancer; 2012 Oct; 51(10):925-32. PubMed ID: 22736493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adenoendocrine cell carcinoma of the gallbladder: differentiation of the endocrine component.
    Hashimoto M; Okuda C; Sakurai C; Seki K; Matsuda M; Nagao G; Ueno M; Watanabe G
    J Gastroenterol Hepatol; 2007 Jan; 22(1):141-2. PubMed ID: 17201900
    [No Abstract]   [Full Text] [Related]  

  • 12. Unique Genetic and Survival Characteristics of Invasive Mucinous Adenocarcinoma of the Lung.
    Shim HS; Kenudson M; Zheng Z; Liebers M; Cha YJ; Hoang Ho Q; Onozato M; Phi Le L; Heist RS; Iafrate AJ
    J Thorac Oncol; 2015 Aug; 10(8):1156-62. PubMed ID: 26200269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EML4-ALK fusion is linked to histological characteristics in a subset of lung cancers.
    Inamura K; Takeuchi K; Togashi Y; Nomura K; Ninomiya H; Okui M; Satoh Y; Okumura S; Nakagawa K; Soda M; Choi YL; Niki T; Mano H; Ishikawa Y
    J Thorac Oncol; 2008 Jan; 3(1):13-7. PubMed ID: 18166835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Relevance of molecular alterations in histopathologic subtyping of lung adenocarcinoma based on 2011 International Multidisciplinary Lung Adenocarcinoma Classification].
    Liu B; Shi SS; Wang X; Xu Y; Zhang XH; Yu B; Lu ZF; Wang JD; Zhou XJ
    Zhonghua Bing Li Xue Za Zhi; 2012 Aug; 41(8):505-10. PubMed ID: 23157740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicoradiologic characteristics of patients with lung adenocarcinoma harboring EML4-ALK fusion oncogene.
    Fukui T; Yatabe Y; Kobayashi Y; Tomizawa K; Ito S; Hatooka S; Matsuo K; Mitsudomi T
    Lung Cancer; 2012 Aug; 77(2):319-25. PubMed ID: 22483782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary signet ring cell carcinoma of female urethra.
    Suzuki K; Morita T; Tokue A
    Int J Urol; 2001 Sep; 8(9):509-12. PubMed ID: 11683973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiplex reverse transcription-PCR screening for EML4-ALK fusion transcripts.
    Takeuchi K; Choi YL; Soda M; Inamura K; Togashi Y; Hatano S; Enomoto M; Takada S; Yamashita Y; Satoh Y; Okumura S; Nakagawa K; Ishikawa Y; Mano H
    Clin Cancer Res; 2008 Oct; 14(20):6618-24. PubMed ID: 18927303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Solitary pulmonary metastasis from lung cancer harboring EML4-ALK after a 15-year disease-free interval.
    Tomizawa K; Ito S; Suda K; Fukui T; Usami N; Hatooka S; Kuwano H; Yatabe Y; Mitsudomi T
    Lung Cancer; 2013 Apr; 80(1):99-101. PubMed ID: 23279872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EML4-ALK translocation predicts better outcome in lung adenocarcinoma patients with wild-type EGFR.
    Wu SG; Kuo YW; Chang YL; Shih JY; Chen YH; Tsai MF; Yu CJ; Yang CH; Yang PC
    J Thorac Oncol; 2012 Jan; 7(1):98-104. PubMed ID: 22124476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mucin-producing gastric cancer: clinicopathological difference between signet ring cell carcinoma and mucinous carcinoma.
    Fang WL; Wu CW; Lo SS; Chen JH; Hsieh MC; Shen KH; Li AF; Tai LC; Lui WY
    Hepatogastroenterology; 2009; 56(93):1227-31. PubMed ID: 19760976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.